Bacteria in the Gut May be a Cause of Lupus and Flares: Shows Study Supported by Lupus Research Alliance
NEW YORK, NY. February 19. Pieces of bacteria that escape from the intestines may trigger lupus and associated disease...
Search Results
You searched for: lupus nephritis
Results found: 1099
MOMENTOUS NEWS — Potential New Lupus Treatment Effectively Reduced Disease Activity in Phase III Trial
NEW YORK, NY. August 29 -- The Lupus Research Alliance is excited to share the good news that a...
B cells and plasma cells in black SLE. Mechanisms of disease heterogeneity
With this landmark award, Dr. Ignacio Sanz and his team of six co-investigators at three highly respected institutions will focus...
Lupus Therapeutics Partners with AbbVie on Clinical Trial Recruitment Efforts in SLE Through LuCIN Lupus Clinical Trial Network
The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, announced a partnership with AbbVie Inc. for the...
Scientific and Technology Breakthroughs Show Promise for Lupus and Other Immunologic Diseases
July 16, 2018.
The Lupus Research Alliance is pleased and very encouraged to share a promising scientific breakthrough reported in...
LRA Response to FDA Authorization of Booster Vaccine for Certain Immunocompromised People
August 13, 2021
As you have probably heard on the news, the U.S. Food and Drug Administration granted late last night...
LRA-Supported Study Discovers How Harmful Immune Cells Develop
August 17, 2020
In a new study published in the journal Immunity, Lupus Research Alliance-funded researcher Dr. Boris Reizis and...
Possible Cancer Drug 2DG May Boost Good Immune Cells
June 20, 2019
The investigational drug 2DG, tested as a cancer treatment, shows promise for lupus in new results reported...
2018 LRA Lupus Insight Prize Recipient Receives $15 M Grant from NIH to Study Lupus Effects on the Brain
July 27, 2020
The Lupus Research Alliance congratulates 2018 Lupus Insight Prize recipient Betty Diamond, MD and the Feinstein Institutes...
Potential New Treatment in Phase III Trial
The Lupus Research Alliance is excited to announce that a potential new medicine for lupus—anifrolumab—reduced disease activity versus placebo...
Unwavering in the Pursuit of Scientific Discovery A Snapshot of 2020’s Triumphs
Despite the uncertainty around COVID-19, the LRA was still able to jumpstart intriguing scientific investigations that hold the promise...
LRA-Funded Research Helps Illuminate Genetic Causes of Lupus
October 19, 2021
Two recent studies funded in part by the Lupus Research Alliance offer a new, more detailed understanding...